Skip to main navigation
Logo - Color

    Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request
  • Our Science
    • Our Science
    • Pipeline
      • RAS Pathway
      • Avutometinib (RAF/MEK Clamp)
      • Defactinib (FAK Inhibitor)
      • Avutometinib as a Backbone of Therapy
    • Clinical Trials
    • Resources
  • Our Medicines
  • Medical Professionals
    • Overview
    • HCP Resources
      • Request Medical Information
      • Medical Education Grants and Scholarships
      • Investigator Sponsored Trials
      • Expanded Access
  • Patients & Advocacy
  • Investors & Media

    Investor Relations

    • Overview
    • News & Media
      • Press Releases
      • Media Resources
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • IR Resources
  • Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request

Corporate Governance

Committee Charters
Audit Committee 95.1 KB
Compensation Committee 168.2 KB
Nominating and Corporate Governance Committee 84 KB
Research and Development Committee 139.3 KB
Commercialization Committee 188.3 KB
Governance Documents
Corporate Governance Guidelines 81.1 KB
Code of Business Conduct and Ethics 190.6 KB
Insider Trading Policy 233.7 KB

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

Audit Committee Compensation Committee Nominating and Corporate Governance Committee Research and Development Committee Commercialization Committee
John Johnson Compensation Committee Nominating and Corporate Governance Committee
Paul Bunn, M.D. Research and Development Committee
Anil Kapur Audit Committee Compensation Committee Commercialization Committee
Michael Kauffman, M.D., Ph.D. Research and Development Committee
Michelle Robertson Audit Committee Compensation Committee
Eric Rowinsky, M.D. Nominating and Corporate Governance Committee Research and Development Committee
Brian Stuglik, RPh Commercialization Committee
Karin Tollefson, PharmD Audit Committee Nominating and Corporate Governance Committee Commercialization Committee
= Chairperson = Member = Lead Director = Financial Expert
  • Terms of Use
  • Compliance & Ethics
  • Copyright Statement
  • Privacy Policy
  • Contact
  • Sitemap
Twitter Linkedin
Verastem logo

© 2026 Verastem, Inc. All Rights Reserved.